Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Men with androgenetic alopecia have different scalp oils and microbes compared to those without.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Dermoscopy improves diagnosis of hair and scalp disorders and can help avoid unnecessary biopsies.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

High mTORC1 activity slows hair growth and causes it to lose color.

Bmpr2 and Acvr2a receptors are crucial for hair retention and color.

Caspases are enzymes important for both cell death and various non-lethal cell functions, affecting head development and hair growth, with different caspases playing specific roles.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

New treatments focusing on immune pathways show promise for stubborn hair loss.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Combination therapies might work better for some vitiligo patients, but results vary.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Certain micronutrients may improve hair and nail health, but more research is needed to confirm their benefits.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Fat cells are important for tissue repair and stem cell support in various body parts.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.